Diabetes, obesity increases risk of liver cancer relapse: Study
New Delhi, Oct 3 (IANS) Diabetes and obesity can fuel the relapse of liver cancer — the sixth most common cancer worldwide, according to a study. The study led by Osaka Metropolitan University, focussed on hepatocellular carcinoma (HCC) — a type of liver cancer associated with hepatitis infections — known to have a high recurrence
New Delhi, Oct 3 (IANS) Diabetes and obesity can fuel the relapse of liver cancer — the sixth most common cancer worldwide, according to a study.
The study led by Osaka Metropolitan University, focussed on hepatocellular carcinoma (HCC) — a type of liver cancer associated with hepatitis infections — known to have a high recurrence rate after cancer removal. It is also the third leading cause of cancer-related deaths globally.
Obesity and diabetes, which are closely associated with metabolic syndrome development, are well known to induce steatotic liver diseases, potentially causing liver cirrhosis and HCC development.
However, obesity and diabetes’ effects on patient survival and cancer recurrence have been unclear.
“Because the risk of late recurrence is higher in hepatocellular carcinoma with comorbid obesity and diabetes, controlling obesity and diabetes is an important treatment strategy for the liver cancer,” said Dr. Hiroji Shinkawa’s research team at the University’s Graduate School of Medicine.
In the study, published in the journal Liver Cancer, the team analysed the relationship between diabetes mellitus, obesity, and postoperative outcomes in 1,644 patients with hepatocellular carcinoma who underwent liver resection.
The results revealed that obesity increased the risk of recurrence two years after the operation approximately by 1.5 times, and in the case of diabetes, the risk was 1.3 times higher.
In addition, the risk of recurrence after five years postoperatively was 3.8 times higher with obesity, while with diabetes it was 2 times higher.
The findings can contribute to the early detection of cancer recurrence and the design of appropriate treatment strategies, Shinkawa said.
Obesity is a common risk factor for type 2 diabetes, and the two conditions are often linked.
Recent research showed that the number of adults with obesity will increase by six times in the next 40 years, while people with diabetes will soar 642 million by 2040.
–IANS
rvt/
ଉଦ୍ଯାପନ ହେଲା ବି.ଏମ୍.ସିର ସ୍ଵଚ୍ଛତା ପକ୍ଷ କାର୍ଯ୍ୟକ୍ରମ
Next ArticleOdisha Raj Bhavan Has Turned into a Political Center: BJD
Related Articles
New AI tool to revolutionise personalised cancer treatment

Health & LifestyleNew AI tool to revolutionise personalised cancer treatment
New Delhi: An international team of scientists has developed an artificial intelligence (AI) tool that could revolutionise cancer treatment by mapping cellular diversity within tumours. The innovation tackles tumour heterogeneity in oncology, where varied cell populations cause treatment resistance and recurrence, Xinhua news agency reported. The AAnet AI tool, developed by the Sydney-based Garvan Institute
Covid-19 virus protein triggers immune attack on healthy cells: Study

Health & LifestyleCovid-19 virus protein triggers immune attack on healthy cells: Study
New Delhi: Amid a fresh wave of Covid-19, Israeli researchers have discovered that a protein from the SARS-CoV-2 virus can cause the immune system to attack healthy cells mistakenly. The study, published in the journal Cell Reports, sheds light on how severe Covid complications may occur and suggests new ways to prevent immune-driven damage from
Global AI collaboration revolutionises personalised cancer treatment

Health & LifestyleGlobal AI collaboration revolutionises personalised cancer treatment
New Delhi: An international team of scientists has unveiled an artificial intelligence (AI) technique that securely analyses global cancer samples, paving the way for more personalised and privacy-protected cancer treatments. This innovative approach promises to accelerate personalised cancer treatment by enabling clinicians to match therapies to individual patients better, Xinhua news agency reported. The study
